CAP Partners, LLC: XYZ position timeline
Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of CAP Partners, LLC on XYZ, newest first. How the timeline and the estimate are built.
CAP Partners, LLC held 0 XYZ shares at 2025-12-31 per its 13F-HR filed 2026-02-04.
the latest 13F is the newest step
- period ended2025-12-3113F 0 sharesChange vs previous 13F -4,019 shares
13F-HR 0002006870-26-000001 filed by CAP Partners, LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
Exited: the 13F for this period no longer lists the position.
- period ended2025-09-3013F 4,019 sharesChange vs previous 13F -380 shares
0.16% of the 13F portfolio, value $290,453.
13F-HR 0002006870-25-000005 filed by CAP Partners, LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-06-3013F 4,399 sharesChange vs previous 13F +145 shares
0.19% of the 13F portfolio, value $298,824.
13F-HR 0002006870-25-000004 filed by CAP Partners, LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-03-3113F 4,254 sharesChange vs previous 13F -297 shares
0.17% of the 13F portfolio, value $231,120.
13F-HR 0002006870-25-000003 filed by CAP Partners, LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2024-12-3113F 4,551 sharesChange vs previous 13F -264 shares
0.27% of the 13F portfolio, value $386,789.
13F-HR 0002006870-25-000001 filed by CAP Partners, LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2024-09-3013F 4,815 sharesChange vs previous 13F not available
0.24% of the 13F portfolio, value $323,231.
13F-HR 0002006870-24-000005 filed by CAP Partners, LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).